Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Male osteoporosis]

R Trèves1, V Louer, C Bonnet

  • 1Clinique Thérapeutique et Rhumatologique, CHU Dupuytren, Limoges.

Presse Medicale (Paris, France : 1983)
|November 20, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ambulatory introduction of foslevodopa/foscarbidopa in Parkinson's disease in private practice. Case series of the first 22 patients.

Revue neurologique·2026
Same author

Short Communication: True Cost Accounting (TCA) as a transformative approach for livestock agri-food systems.

Animal : an international journal of animal bioscience·2025
Same author

Spinocerebellar ataxia 27B (SCA27B), a frequent late-onset cerebellar ataxia.

Revue neurologique·2024
Same author

Megalencephaly secondary to a novel germline missense variant p.Asp322Tyr in AKT3 associated with growth hormone deficiency and central hypothyroidism: A case report.

American journal of medical genetics. Part A·2024
Same author

ENPP1 homozygous stop-loss variant causing generalized arterial calcifications of infancy: About a severe neonatal clinical case.

European journal of medical genetics·2023
Same author

Extracellular miR-6723-5p could serve as a biomarker of limbal epithelial stem/progenitor cell population.

Biomarker research·2022

Osteoporosis in men is a growing public health concern, with increased fracture risks due to aging populations and specific male risk factors. Early diagnosis and tailored treatments are crucial for managing this condition.

Area of Science:

  • Endocrinology
  • Geriatrics
  • Public Health

Context:

  • Recent focus on osteoporosis in men highlights a significant public health issue.
  • Men typically have higher bone mass but face increased fracture risks, particularly post-trauma.
  • An increasing incidence of masculine osteoporosis and vertebral fractures is observed, linked to population aging.

Purpose:

  • To review the current understanding of osteoporosis in men, including its contributing factors and diagnostic considerations.
  • To outline the key etiological factors predisposing men to osteoporosis.
  • To emphasize the importance of comprehensive pretherapy work-up and appropriate therapeutic strategies.

Summary:

  • Key risk factors for male osteoporosis include hypoandrogenism, hypoestrogenism, alcohol-smoking association, malnutrition, lack of sun exposure, and chronic liver disease.

Related Experiment Videos

  • Other potential causes encompass hyperthyroidism, Cushing's disease, hemochromatosis, inflammatory rheumatic diseases, and iatrogenic factors.
  • Comprehensive evaluation is necessary to identify all potential etiologies before initiating treatment.

    • Impact:

    • Highlights the need for increased awareness and research into male osteoporosis.
    • Informs clinical practice regarding the investigation and management of osteoporosis in men.
    • Underscores the importance of addressing lifestyle factors and underlying conditions for effective treatment.